Crossref
FDA Approves First Oral Carbapenem for Complicated UTIs
JAMA · 04.08.2026 · 336 (5) · 363
DOI: 10.1001/jama.2026.9474 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 04.08.2026. Verfasst von Samantha Anderer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderer, S. (2026). FDA Approves First Oral Carbapenem for Complicated UTIs. JAMA, 336(5), 363. https://doi.org/10.1001/jama.2026.9474
Vancouver
Anderer S. FDA Approves First Oral Carbapenem for Complicated UTIs. JAMA. 2026;336(5):363. doi:10.1001/jama.2026.9474
BibTeX
@article{Anderer2026,
author = {Anderer, Samantha},
title = {FDA Approves First Oral Carbapenem for Complicated UTIs},
journal = {JAMA},
year = {2026},
volume = {336},
number = {5},
pages = {363},
doi = {10.1001/jama.2026.9474}
}
EUVIMED